In patients with gastric and OGJ type III tumours, NET1 positive patients were more likely have advanced stage cancer (p = 0.03), had a higher number of transmural cancers (p = 0.006) and had a significantly higher median number of positive lymph nodes (p = 0.03). This evidence concerns the gene NET1 and cancer.